Enterome

French tech company | Builders Republic

About

Clinical-stage immunotherapy biotech developing cancer and immune-disease treatments based on molecular mimicry — exploiting the resemblance between gut-bacteria proteins and tumor markers to trigger targeted immune responses, built on a discovery platform that decodes interactions between the gut microbiome and the immune system.

Key facts

Status
Active
Sectors
Healthcare & Life Sciences
Latest stage
Venture Round
Founded
2008
City
PARIS
Region
IDF
Tracked rounds
1
Amount raised
17 M€ raised since 2020

Funding rounds

  • Venture Round — 2025

Investors